WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events
Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches
Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production
Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
Investival Showcase USA
-
BIA – Advanced Therapies 2026 Congress
-
BIO Europe Spring
-
Analytica
DNA Script expands global access to on-demand DNA synthesis with distributor agreements in Latin America and East Asia
Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hours Establishes direct distribution networks across Latin America, Japan and South Korea Paris, France, 17 March 2026: DNA Script, a pioneer [...]
Lab Thread launches free version of Unified Lab Software Platform to accelerate academic research
Free-to-use software version available for academic and non-profit researchers worldwide Intuitive system provides robust data management tools to support scientific collaboration and engagement with funding bodies through streamlined adherence to [...]
VALANX Biotech secures €3 million to advance LIV-1 ADC for metastatic triple-negative breast cancer
Foundation Fournier-Majoie and FUJIFILM Corporation join existing VC and angel investors including xista science ventures, tecnet equity and SOSV Financing advances VLX-ADC-001, a LIV-1 targeting ADC, with candidate nomination planned [...]



















